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Recent advances  in the study of experimental arterial hypertension have
suggested  that  the  elevated  blood  pressure  results  from  an  increase  in
peripheral  resistance  caused  by the presence  of  a pressor substance  circu-
lating  in  the  blood  stream.  This  humoral  vasoconstrictor  is  probably
released  by the kidneys  when  their blood flow  is reduced.  Although  the
nature  of  the pressor  substance  is unknown,  some have  suspected  that it
might  be  of  relatively  simple  chemical  structure.  Victor  has  found  a
highly  pressor  dialyzable  material  in  the anaerobic  autolysate  of  kidneys
(1);  Page  has  isolated  "angiotonin"  from  the  interaction  of  renin  and  a
globulin  in  plasma  (2).  "Angiotonin,"  a  dialyzable  substance,  requires,
however,  "an activator"  for its pressor  action  (3).
Barger  found  that many  phenolic  compounds  containing  an  aliphatic
amine as a side chain are strong pressor substances,  the most potent being
aminoethanol  catechol,  which  is closely allied  to adrenalin  (4).  Although
other  amines  may exhibit  a  pressor  action,  the most powerful  appear  to
contain  a  catechol  configuration  in  the molecule.
It appeared  possible  that  the pressor  substance  responsible  for  hyper-
tension is a simple  pressor amine, released  by ischemic  kidneys because  of
an alteration  in  the  action  of  some  system  of  enzymes  requiring  oxygen.
Justification for this conception  is found in the work  of Holtz  (5),  who was
able  to  demonstrate  by  experiments  in vitro that  while  renal  tissue  was
able  to  decarboxylate  tyrosine  and  di-hydroxyphenylalanine  (dopa)  in
the absence of oxygen, deamination occurred only when oxygen was present.
His results suggest,  therefore,  that an amine oxidase is present in kidneys.
When  it  is  remembered  that  the  product  of  the  decarboxylation  of  di-
hydroxyphenylalanine  is hydroxytyramine,  a pressor substance,  and of the
deamination  di-hydroxyphenylacetic  acid,  which  is  inert,  this  theory
becomes  tenable.  Further  substance  would  be given to  this idea  if these
renal enzymes were not specific  for tyrosine  and dopa,  but acted upon all
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amines in like manner;  that is to say, by deamination  only in the presence
of oxygen.
If hypertension  were due  to  a pressor  amine  released  by kidneys  which
are  deficient  in  oxygen  supply  it would  seem  rewarding  to  ascertain  the
effect upon the blood pressure of hypertensive animals of certain substances
capable  of  altering  pressor  amines.  Because  the  most  powerful  pressor
substances  known  contain  phenolic  configurations  in  their  molecules,  it
is  reasonable  to  study  first  enzymes  active  against  that portion  of their
structure, especially since the known amine oxidases have not been purified.
For this  reason  pure  specific  oxidative  enzymes  were  selected  for  this  in-
vestigation.
Tyrosinase,  very  common  in  fruits  and vegetables,  has  the  property  of  oxidizing
mono-  and ortho-di-hydroxyphenols  to  quinones  (6).  When  certain  physiologically
active phenolic amines are acted upon by this enzyme, derivatives  are formed which  are
inactive  on the  vascular  system.  The  conversion  of adrenalin  to  adrenochrome  and
tyramine  to melanin  are examples  (7).  An  attempt  was made,  therefore,  to learn  the
effect of tyrosinase upon  the blood pressure  of hypertensive  animals.
Materials and Methods
The preparation  of the enzyme used in this study was obtained from Dr. J. M. Nelson
who has isolated it from mushrooms  (8).  Tyrosinase is a water-soluble  protein combin-
ing  in  itself  two  types  of  enzymatic  activity.  It  catalyzes  the  oxidation  of  mono-
hydroxyphenols  to catechol derivatives and also the oxidation  of catechol derivatives  to
orthoquinones; thus completely destroying the phenolic configuration of these compounds
(Text-fig.  1).  This  makes  an  ideal  preparation  for  the  present  use,  since  its  action
applies  to  all  compounds  containing  a  free  mono-  or  ortho-di-hydroxyphenolic  con-
figuration.
Forty-four rats were  made  hypertensive by one  of three methods.  One was that of
Goldblatt  as reported by Rytand  (9).  One renal artery was partially constricted,  in a
few instances  the other kidney being removed.  In rats at least, this procedure  induced
hypertension  quite  uniformly,  whether  or  not  the  normal  kidney  was  left  in  place
(Table  I).
The  second  method involved  the  production  of unilateral  hydronephrosis;  since  it
has not been reported it will be described  in detail.  Rats were anesthetized by pento-
barbital  sodium injected into the peritoneum.  A diagonal incision was made  along the
course of the lowest rib  on the left, extending anteriorly and caudally to the lower third
of the abdomen.  The ureter  was exposed  as it left the kidney, and dissected  free to a
point near its insertion  in the bladder.  It was there tied, cut, and brought out through
the skin  in  the  upper angle  of the wound.  The end was  sutured to  the skin  and the
wound closed.  At the end of a day or two it was found that the part of the ureter out-
side of the animal had sloughed, and as healing took place  with resultant contraction  of
scar tissue,  hydronephrosis  developed  while  the kidney  continued  to function.  In no
case was hydronephrosis  of marked degree,  and hypertension,  as judged by elevation  of
blood pressure and cardiac hypertrophy, consistently resulted  (Table II).
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The third method involved traumatic injury to one kidney.  Rats were anesthetized
and  the  left  kidney  isolated  in  a fold of skin in  the flank.  By placing the  handle of
a clamp  over the  kidney  it could be  firmly  fixed  in position.  The  kidney  was  then
pounded gently with a blunt object through the unopened skin.  Hypertension  resulted
in about half of  these  animals  (Table III).
Rats  were  regarded  as  exhibiting arterial  hypertension  when both  of the  following
phenomena were  observed.  (a) Diastolic blood pressure  under anesthesia at  the level
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TEXT-FIG.  1.  The oxidation  by tyrosinase  of tyramine  to melanin  according  to Du-
liere  and Raper  (7).  Both  tyramine  and hydroxytyramine  are pressor substances,  the
latter being the stronger.
of  110 mm. Hg.  (b) Enlargement  of the heart, its weight being  12 per cent or more than
that expected,  according  to the formulae:
Males:  Heart weight  (mg.)  12.6  body weight  (gm.)0-7.  + 8
Females:  "  "  "  =  12.45  "  I  "  0.75  +  1.5  (Rytand)
One animal with a diastolic pressure of 102 mm. Hg was included in this series because its
cardiac  enlargement  was  27  per  cent  more than  expected.  The  hearts  of  none of the
normal rats were hypertrophic,  although the diastolic pressures  of six were greater than
110 mm. Hg (Tables IV and VI).
When  injections were  to be made, rats were  anesthetized with pentobarbital  sodium
given into the peritoneal cavity.  The right femoral artery was exposed,  and a drop  of
strong novocaine solution  was placed  on it to prevent  contraction.  A  23 gauge needle
connected to Hamilton's optical manometer was inserted into the artery through a small
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TABLE  I
Diastolic  Pressure  and Heart Weight  of Rats
Rat No.  Weight  Weight of heart  Time after  Diastolic
Expected  I  Observed  I  Change  operation  pressure
A.  Partial Occlusion  of Left Renal Artery
gm.  gm.  gm.  per cent  days  mm. Hg
G  103  376  1.084  1.60  +48  11  -
G  121*  353  1.036  1.51  +46  11  110
G  107*  340  1.006  1.46  +44  6  (58)t
G  123*  328  0.978  1.33  +36  15  128
G  106*  320  0.961  1.27  +32  5  104
G  115*  334  0.988  1.26  +27  7  120
G  112*  273  0.854  1.08  +26  3  (62)t
G  108  351  1.030  1.30  +26  12  (64)t
G  116  318  0.955  1.20  +26  21  98
G  122*  313  0.946  1.18  +25  15  110
G  110  316  0.952  1.17  +23  42  110
G  117*  342  1.008  1.24  +23  8  132
G  113*  336  0.989  1.21  +22  12  110
G  127*  332  0.987  1.21  +22  12  90
G  111  365  1.060  1.30  +22  12  -
G  105  326  0.975  1.18  +21  12  -
G  104*  328  0.979  1.16  +18  32  134
G  124  437  1.212  1.40  +15  1  -
G  126  336  0.989  1.14  +15  8  80
G  118  346  1.011  1.09  +8  13  82
Average .........................................  +26.3  113.3
B.  Partial Occlusion  of Left Renal Artery and Right Nephrectomy
GN  128  377  1.078  1.51  +40  3  -
GN  135*  300  0.909  1.24  +36  7  114
GN  130  346  1.011  1.34  +33  3  -
GN  140*  326  0.975  1.29  +32  5  128
GN  129  350  1.030  1.32  +28  3  -
GN  102  403  1.141  1.37  +20  4  -
GN  137  336  0.998  1.19  +19  5  -
GN  132  386  1.105  1.31  +19  2  90
GN  139  342  1.008  1.16  +15  4  -
GN  136  360  1.049  1.19  +13  2  -
GN  119  337  0.999  0.93  --7  7  80t
Average .........................................  +25.5  113.0
All rats were males.
* Animals injected with tyrosinase.
t  Animal  in shock  when  blood  pressure was  measured.
:  Kidney not ischemic.TABLE  II
Diastolic Pressure  and Heart Weight of Rats
Left hydronephrosis owing to explantation of ureter
Weight of heart  Time after  Diastolic
Rat No.  Weight  operation  pressure
Expected  Observed  Change
gm.  gin.  gin.  per cent  days  mm. Hg
H  96  326  0.968  1.31  +35  15  95t
H  99  381  1.083  1.42  +31  23  112t
H  150  375  1.082  1.42  +31  33  -t
H  95*  346  1.010  1.28  +27  15  102t
H  97*  394  1.095  1.37  +25  30  126t
H  94*  333  0.990  1.17  +18  28  110t
H  100*  353  1.028  1.18  +15  27  112t
H  93*  350  1.010  1.13  +12  22  128t
Average ................... +.................  - 24.2  112.1
H  149  380  1.092  1.15  +6  33  60t
H  147  356  1.038  1.07  +3  33  58:
H  143  370  1.071  1.06  -1  42  521
H  141  330  0.981  0.95  --3  42  601
H  145  337  0.999  0.97  --3  33  62$
H  146  394  1.113  1.07  -6  33  58:
All rats were males.  t  Kidney  continued to function.
* Animals injected with tyrosinase.  1 Complete  occlusion  of ureter.
TABLE  III
Diastolic Pressure and Heart Weight of Rats
Unilateral renal injury  (trauma)
Rat No.  Weight  Weight  of heart  Time after  Diastolic
trauma  pressure
Expected  Observed  Change
gm.  gm.  gim.  per cent  days  mm. Hg
I  21  231  0.755  0.99  +31  24  (50)t
I  3  260  0.823  1.05  +28  6  -
I  22*  533  1.406  1.73  +25  30  138
I  19*  300  0.909  1.12  +23  30  112
I  9*  370  1.071  1.30  +21  120  112
I  10  350  1.030  1.22  +18  122  (72)t
I  13  310  0.887  1.03  +16  120  114
Average  ....................................... +..  23.1  119
120  345  1.009  1.08  +7  24  84
I  11  350  1.030  1.08  +5  122  -
I  2  316  0.952  0.99  +4  9  (42)t
I  5  363  1.056  1.08  +2  7  80
I  4  411  1.158  1.14  --1  35  62
I  17  367  1.063  1.04  --2  81  100
I  14  312  0.889  0.84  --6  150  110
I  1  337  1.002  0.93  -7  72  86
All rats were males.
* Animals injected with tyrosinase.
t  Animal in shock when blood pressure was measured.
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Diastolic Pressure  and Heart Weight of Rats
Normal animals
Weight
gm.
252
286
375
384
326
286
286
344
276
350
300
340
326
322
256
286
Weight of heart
Expected
gm.
0.796
0.875
1.082
1.103
0.975
0.875
0.875
1.009
0.861
1.030
0.909
1.006
0.975
0.964
0.805
0.875
Observed
gm.
0.89
0.97
1.17
1.18
1.03
0.91
0.87
1.00
0.84
0.98
0.86
0.95
0.90
0.88
0.73
0.79
Average .................................................
All rats were males unless otherwise designated.
* Animal in shock when blood pressure was measured.
TABLE  V
Diastolic  Blood Pressure  in Mm. Hg, before and after the Injection of Tyrosinase
Abnormal animals
15  min.  30 min.
Rat No.  Dose  Control  after  after  30  Remarks
injection  injection
units  mm. Hg  mm. Hg  mm.  Hg  mm.  Hg
H  93  225  120  50  70  -50  85 at 24 hrs.
H  94  450  110  81  65  -45  82 at 70 min.
H  95  180  102  50  65  -37  70 at  2 wks.
H  97  450  126  93  85  -41
H  100  225  112  52  82  -30  60 at  5 days
G  104  360  134  86  100  -34  92 at  2 wks.
G  113  225  110  65  69  -41  82 at 98 min.
G  115  450  120  102  74  -46
G  117  360  132  86  92  -40  82 at 75 min.
G  121  225  110  104  80  -30  72 at 80 min.
G  122  225  110  100  72  -38  62 at 75  min.
G  123  270  128  90  88  -40  100 at  17  days
GN  140  450  128  75  68  -60  85 at 75  min.
I  9  500  112  62  70  -42
I  19  337  112  60  60  -52
I  22  180  138  108  96  -42  80 at 70 min.
Average...  320  M =  119  79  77  M  =  -42
=  7.6
536
Rat No.
P  99
P  139
509
43
.P  79
P  169
P  149
34
P  5
29
P  8
28
P  17
33
P  129
P  159
Change
per cent
+11
+11
+8
+7
+6
+4
0
-1
-2
-5
-5
-6
-8
-9
--9
-10
-0.5
Diastolic
pressure
mm. Hg
90
75
90
88
70
110
86
104
104
92
100
95
110
42*
86
89.5
￿
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of heparin was injected intravenously to prevent clotting in the needle of the manometer.
It  was  sometimes found necessary  to perform  tracheotomy.  One subsequent  measure-
ment of blood pressure and rarely two could be made by using the left femoral artery.
The  Effect  of Tyrosinase on Hypertensive  Rats
The injection of tyrosinase into 16 hypertensive rats was always followed
by a fall of blood pressure to normal  (Table V).  In no case  did the blood
TABLE  VI
Diastolic  Blood Pressure in Mm. Hg, before and after  tLe Injection of Tyrosinase
Normal animals
Rat No.
22
23
24
26
27
28
29
31
32
33
34
35
36
37
39
40
41
42
43
45
56
80
Average....
Dose
units
225
225
225
360
225
340
315
450
360
225
225
225
225
225
225
450
450
225
225
225
500
450
300
Control
m.  Hs
90
60
75
115
100
70
94
114
85
108
80
105
100
136
90
80
122
102
102
85
70
80
M  =  93
15 min.
after
injection
mm. Hg
121
70
70
95
100
50
70
100
118
110
86
126
112
144
112
65
126
104
110
86
70
65
M = 95
30 min.
after
injection
mm. Hg
110
60
79
80
100
52
60
100
114
87
92
120
112
136
65
122
98
114
82
87
M  93
Change  at
30 min.
mm.  Hg
+20
0
+4
-35
o
-18
-34
-14
+29
-21
+12
+15
+12
-15
o
-4
+12
-3
+7
M=  0
a  =  16.6
Remarks
110 at 62 min.
60 at 61 min.
79 at 64 min.
55 at 55  min.
112 at  17 days
106 at  9 days
110 at 60 min.
104 at 70 min.
98 at 45 min.
110 at 60 min.
pressure  subsequently  rise  to  previous  levels.  The  intravenous  injection
of this enzyme into  22 normal rats gave variable results  (Table  VI).  The
action of this material was always  delayed, no effect  being observed,  except
for a slight  initial depression,  until 5  to  15  minutes  had elapsed  (Fig.  1).
There  was  a  distinct  difference  between  the  responses  of normal  and  of
hypertensive animals (Text-figs. 2 and 3).  The dose used by the intravenousEFFECT  OF  TYROSINASE  ON  HYPERTENSION
TEXT-FIG.  2.  The curves  represent  the averages of the blood pressures of  20 normal
and  15  hypertensive  rats  after  the  injection  of  tyrosinase.  The  values  are given  in
mm. Hg.
In  crder OtJ :Plil  a1lO5LtiC  p-ressure
Highest - Lowest
TEXT-FIG.  3.  The change in the diastolic  blood pressure of rats  30 minutes after the
injection of tyrosinase.  Experiments are shown in the order of the initial diastolic pres-
sure  of both the normal and  hypertensive animals.
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route lay between  180 and 500 units.'  The only toxic effect observed sub-
sequently was the development  of diarrhea in three of the animals, a day or
two later.  In every hypertensive  rat the heart rate was  slowed when the
injection had taken  effect; this reduction  was abolished by the administra-
tion  of  atropine  without  altering  the lowered  blood  pressure.  Injections
of the enzyme when it had been inactivated by heat (900C. for  10 minutes)
did  not  affect  blood  pressure.
Later effects  upon blood pressure  were observed in five  animals, in none
of  which  did  hypertension  reappear  (Table  V).  These rats  did  not lose
weight and  seemed  to be  healthy  in every respect.
The  Effect  of Tyrosinase on Hypertensive Dogs
Chronic  arterial  hypertension  was  induced  in  dogs  by  the  method  of  Goldblatt.
Usually  one  renal artery  was  partially  constricted  and the other  kidney  removed, al-
though  one  dog exhibited  persistent  hypertension  for  many months  after partial  con-
striction of one renal artery alone.  Estimations of blood pressure were made by the use
of  Hamilton's  optical  manometer,  the  needle  of  which  was  inserted  into  the  femoral
artery.  Injections  of  tyrosinase  were  made  by the  intravenous  or, in two  instances,
by the intramuscular route.
Effects  somewhat  similar  to  those  in rats  were  seen.  Single  injections
into  four hypertensive  unanesthetized  dogs  were followed  by marked falls
in  blood pressure  lasting from  3 to 48 hours.  Doses varied  from 5000 to
20,000 units  (10 to 40 mg. protein by dry weight).  In three normal  dogs
there  was  less change  in pressure  (Table  VII A).
Because the effects of the administration of this enzyme were of relatively
short duration,  four dogs were  treated  by daily intravenous  injections  of
200  units  per  kilo  (Table  VII B).  The  blood  pressures  of  all fell  slowly
after several  days,  remaining  considerably  reduced  for  several  days  after
the injections were discontinued, and slowly returning to the previous level.
Similar  treatments  given  to  two  normal  dogs  resulted in  one  in a  rise  in
the level of blood pressure and in the other in a slight fall (Text-figs.  4 and 5).
Dogs remained healthy and did not lose weight.  When large doses were
given by the intravenous route, certain symptoms and signs were noted for
an  hour  or  two  after  the  injections.  These  consisted  of marked  fall  in
blood  pressure,  vomiting,  diarrhea,  and bradycardia.  Occasionally  there
was  a  rise  in  body  temperature  of  1-2°C.  24  hours  later  bradycardia
sometimes persisted  although  the animals appeared  otherwise  unchanged.
In two  experiments bradycardia  was abolished after the administration  of
atropine, although there was no rise in the level of the blood pressure.
I  One unit has been  defined as the amount  of enzyme required to cause a solution  of
hydroquinone  and catechol  to absorb oxygen  at the rate  of  10  c.mm. per minute  (10).
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TABLE VII
The Efect of the Injection of Tyrosinase on  the Blood Pressure of Dogs
Range of blood pressure
RDngeof  boodpresBlood  pressure after injection  Change
DN.  Date  Dose  Before injection  in-  24  Remarks
Highest  Lowest  Average  section  3 hrs.  I day  2 days  3 days  6 days
A. Single  Doses
1940  nins  mm. Hg mm. Hg smm. Hg  mm.  . g  m.  Hg  m.  Hg  mm.  Hg  mm.  Hg  mm.  Hg  .Hg
2-9  Mar.  7  5,000  228/124  190/95  202/111  220/122  160/106  160/104  182/106  190/126  -60/-18  Goldblatt hy-
pertension
Apr. 16  6,000  235/124  190/110  178/102  -57/-22
17  15,000  178/102  194/96  194/104  224/111  222/102  +16/  -6
23  15,000'  224/104  170/92  177/94  200/90  225/114  -47/-10
July 31  13,500  198/106  176/99  198/102  165/74  0/ -4
3-9  Apr.  16  6,000  265/159  218/122  230/136  218/124  200/133  210/132  -8/  +8  Goldblatt  hy-
17  15,000  210/132  168/120  200/125  198/114  240/138  -42/-12  pertension
23  15,000  240/138  168/120  180/130  218/120  225/120  -60/  -8  (unilateral)
5-2  Apr.  16  6,000  240/145  190/104  209/118  218/124  144/110  178/122  -40/  -2  Goldblatt  hy-
17  15,000  178/122  165/116  175/108  195/130  214/122  -13/  -6  pertension
23  15,000"  214/122  170/100  175/112  208/114  190/124  -- 39/--10
5-6  Apr.  16  6,000  178/101  136/76  155/90  152/76  165/110  130/78  178/96  172/96  178/98  -22/  +2  Normal
6-1  Oct.  10  16,500  225/122  191/90  196/108  225/122  157/122  210/108  219/97  185/92  -15/-14  Normal  with
elevated blood
pressure
6-8  Oct.  10  16,500  202/120  180/98  192/110  201/120  210/130  219/110  193/110  185/102  +18/-10  Normal  with
elevated blood
pressure
B.  Multiple  Doses
No~g Dat  Initial  Number  Blood pressure, days after first injection Dog  Iiti  Daily  of  Remarks Date  blood  injec-
pressure  |  tions  7 days  8 days  12 days  14 days  18 days  21 days  25 days
1940  mm. Hg  units  mm. Hg  mm.  Hg  mm. Hg  mm. Hg  mm.  Hg  mm. Hg  mm. Hg
2-9  May 9  192/124  2,600  8  204/110  194/108  180/104  166/88  192/104  200/122  228/120  Goldblatthyper-
tension
3-9  May9  204/140  2,300  8  216/126  218/124  174/104  192/110  196/114  216/124  220/110  Goldblatt  hy-
pertension
5-2  May 9  190/130  4,200  8  188/114  176/110  156/96  164/102  188/102  220/128  208/110  Goldblatt  hy-
pertension
5-3  May 9  226/144  3,000  8  184/110  204/136  184/108  200/110  190/120  216/124  230/136  Goldblatt  hy-
pertension
5-8  May 9  166/96  2,800  8  194/112  164/106  156/76  190/98  160/88  175/82  160/95  Normal
6-1  May 9  186/126  2,500  8  240/148  210/126  194/110  182/110  200/112  204/116  190/92  Normal
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Renal function  was measured roughly by the amount of urea nitrogen  in
the blood.  In every  instance values  were  less after the injection  of  tyro-
sinase  (for example,  see  Text-figs.  4  and  5).  The  clearance  of  urea  was
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TEXT-FIG.  4.  The  effect  of the injection  of tyrosinase  on the  blood pressure  of  two
dogs.  A, dog 3-9, hypertensive.  B, dog 5-8, normal.  The upper curve indicates  systolic
pressure,  the lower,  diastolic.  The hatched area  represents the  difference  between  the
highest  and the lowest single readings  during the control period.  Averages  are shown.
All doses are in catechol units.  B.  U. N. means urea nitrogen in the blood.  From the
point marked X the curves  are smoothed by the  method of running averages  of three.
The lowest levels  reached are shown by circles.
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estimated in each  of  six dogs when  daily injections  were being  given and
showed no deviation  from  the normal.  Albuminuria  and hematuria when
present did not change  while  dogs were being  treated.
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TEXT-FIG. 5. Notations same as Fig.4.  A, dog 5-2,hypertensive.  B, dogs5-6and6-1,
normal.
The  Duration of the Presence of  Tyrosinase in the  Blood Stream
After single  intravenous  injections,  tyrosinase was detected  in the blood
of dogs for 24 hours (Text-fig.  6).  No trace of this enzyme has been found
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in the blood of dogs or of human beings after subcutaneous or intramuscular
injections.  As yet, no correlation between the amount of tyrosinase present
in the blood and the duration  of the fall in blood pressure  has been estab-
lished.  Although  the enzyme  is active  in  dogs  when given  by  the intra-
muscular route its presence cannot be demonstrated in the blood.
The Mode  of Action  of Tyrosinase in Hypertension
Attempts  were made to  ascertain  the mode of action  of this enzyme  in
animals,  especially  as regards  its  effect  upon  various  pressor  substances.
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TEXT-FIG.  6.  The concentration  of tyrosinase  in the blood of two hypertensive  dogs
at various intervals  of time after  intravenous injection.  The amount was measured in
the Warburg apparatus.  Values obtained after 7 hours are not accurately determinable,
but indicate  that  traces  of enzyme  are  still present.  The  value obtained  at 48  hours
showed a doubtful trace.
25 rats and  eight dogs,  both  hypertensive  and normal,  were used  in  brief
experiments.
Renal blood flow was  measured in dogs by the method of Schroeder and Steele  (11),
using  a thermostromuhr.  Blood pressures  were  recorded  by  Hamilton's  manometer.
Six solutions were  used:  Renin was prepared by  Dr. Alfred E.  Mirsky and concen-
trated to a point at which 0.1 cc. consistently produced a pressor response  in rats weigh-
ing  300 gin.  or  more.  The  dose  of this  material  in normal dogs  amounted  to  1.0  cc.
The  solution  of tyrosinase contained  500 units  per  cc.  The solution  of  catechol-hydro-
quinone  (hereafter called  C-H)  contained  5.0  mg.  hydroquinone  and  0.1  mg.  catechol
per cc., buffered in a phosphate solution at pH 6.5, a standard substrate for the enzyme.
Adrenalin consisted of the usual 1:1000 solution diluted with normal saline according  to
the  amount  required.  The  solution  of  tyramine hydrochloride  contained  4.0 mg.  per
cc.  Angiotonin was obtained from Dr. Irvine H. Page; 0.05 cc. was one "rat dose"  rais-
ing the  diastolic pressure 50 mm. Hg after intravenous injection.
Tyrosinase and Renin.-When a single dose of renin which had not been
freshly dialyzed was shaken with a single  dose of tyrosinase for 20 minutes,
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it  was  found  that  the  renin  was  completely  inactivated.  When  freshly
dialyzed  renin  was  used,  the  response  of  the  blood  pressure  of  dogs and
rats was  lessened  but not  abolished.  The  addition  to this mixture  of the
solution of catechol-hydroquinone  resulted  in complete  inactivation  of  the
renin, C-H itself having no effect  when mixed with renin alone (Table VIII).
The addition of whole blood to a renin-C-H or to a renin-tyrosinase  mixture
resulted  in marked  fall  in  blood  pressure.
Experiments  were  performed  in  the  Warburg  apparatus  to  ascertain
whether tyrosinase acted directly upon renin, or acted through the medium
of some other substance.  Renin which had  stood for several weeks  in the
cold  was shaken with tyrosinase;  absorption of oxygen occurred,  suggesting
that  a  substrate  for  tyrosinase  was  present.  No  oxygen  was  absorbed
when renin which had been freshly dialyzed was treated in the same manner.
A mixture  of fresh renin,  tyrosinase,  and C-H absorbed  oxygen  (owing to
the presence  of C-H,  a substrate)  and was inactive  on the blood pressure.
In the first  instance,  therefore,  some product  of  the deterioration  of renin
acted as a substrate for the enzyme  and allowed inactivation of renin.  In-
activation likewise  occurred when C-H had reacted  with tyrosinase.
Tyrosinase and Angiotonin.-When tyrosinase and angiotonin, amounting
to one  rat dose of each,  were  shaken at  room temperature  for  20 minutes
and  injected  intravenously  in  rats,  the mixture  was  found  to  have about
one-third  of  the  pressor  activity  of  angiotonin  alone.  The  addition  of
catechol  did  not  change  the  result.  But when  0.1  cc.  of  rat  plasma  or
rabbit serum was added to tyrosinase and angiotonin, the resultant mixture,
after  shaking,  was  found to  be completely  inactive  on the  blood pressure
(Fig.  2 A).  Substitution of  gelatin for  serum resulted  in partial inactiva-
tion.  These  results  were  observed  in  five  experiments.  As was  the  case
with adrenalin,  the injection  of tyrosinase  before  or immediately  after the
administration  of angiotonin  resulted  in  a  modified  pressor  response.
When tyrosinase  (two and one-half units) and angiotonin  (one rat dose)
were  shaken  together  in  the  Warburg  apparatus,  oxygen  was  absorbed
slowly, and the resulting mixture was found to have lost none of its pressor
activity.  The addition  of a small amount  of serum resulted in more rapid
and  complete  absorption  of  oxygen,  and  this  mixture  was  completely  in-
active on the blood pressure  of rats (Fig.  2 B).  Tyrosinase  and serum,  or
tyrosinase  and  gelatin,  did not  cause  absorption  of  oxygen,  and  were  in-
active  on  the  blood  pressure.  Several  hours  of  shaking  in  the  Warburg
apparatus were  necessary  to cause  complete  inactivation  of  angiotonin by
small  amounts  of  tyrosinase  and  serum.
Tyrosinase and Other Pressor Substances.-Tyrosinase inactivates  adre-
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TABLE  VIII
The Action of Various Mixtures of Tyrosinase and Renin on the Blood Pressure  of Normal Rats
Solution
Renin, old
Renin, fresh
{Renin,  old
Tyrosinase
{Renin,  fresh
Tyrosinase
Renin,  old
Tyrosinase
C-Ht
Renin, fresh
Tyrosinase
C-H
Whole rat blood
Renin
C-H
Blood
Renin
C-H
Blood
Tyrosinase
Renin
Blood
Tyrosinase
Tyrosinase
(Blood
Num-
ber of
experi-
ments
10
5
5
3
2
3
2
2
3
3
3
2
3
2
How treated
room  emperaturs
Shaken,  15 min.
Shaken,  15 min.
Shaken,  15 min.
Shaken, 20 min.
Shaken,  15  min.
Shaken,  15 min.
Shaken,  15 min.
Shaken,  15 min.
Shaken,  15  min.
Shaken,  15 min.
Standing,  1 hr.
Standing,  10 min.
Shaken,  10 min.
Shaken, 20 min.
Shaken,  15 min.
Shaken, 20 min.
Shaken, 20 min.
The amount of each solution  given  was 0.2 cc.
* +  indicates  rise of blood pressure; - indicates  fall.
t  C-H  =  catechol-hydroquinone  mixture.
Color
change
0
0
0
0
Dark
Dark
0
0
0
0
0
0
0
0
0
Dark
Dark
Pressor effect*
0
++
0
0
0
0
0
++
- - -- (died)
---- (died)
---- (died)
...-  (died) ----  (died)
--- ￿----- --- ------------
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nalin  in vitro  almost  instantaneously.  Tyramine  is  likewise  inactivated
although  less  rapidly.  When  tyrosinase  had been  given  to a  dog  or rat,
the  subsequent  injection  of  tyramine  or  adrenalin  resulted  in  a  modified
response,  characterized  by  less  elevation  of  the blood  pressure  of shorter
duration,  and  sometimes  by  transient  depression  of  blood  pressure after
the  pressor effect  was  over.
A quantity of the pressor material obtained from the anaerobic autolysate
of renal tissue, prepared by Dr. Joseph Victor,  was used in various experi-
ments.  Tyrosinase  was  found  to  render  this  material  inactive  both  for
dogs  and rats.  When it was shaken  with tyrosinase at room temperature,
a depressor  response  upon injection  was noticed  in all of  six rats and  two
normal  dogs.  The  presence  of  catechol-hydroquinone  solution  was  not
necessary  for  this  change  in  effect.  The  injection  of  tyrosinase  into  an
animal  was  found  to  modify  the  pressor  response  of  this material  when
injected subsequently;  similarly,  the  injection  of  tyrosinase  at  the height
of  the pressor  response resulted  in a fall in blood pressure.  In one hyper-
tensive dog, the injection of tyrosinase was found to abolish both the hyper-
tensive state and the further elevation of blood pressure which had resulted
from the administration  of Victor's material.
Renal  blood flow in four normal dogs, measured by the thermostromuhr,
was  at first  reduced  after  the  injection  of  tyrosinase,  and then increased.
The  reaction  of  the  blood  flow  to adrenalin  by the  ischemic  kidney was
reversed in two experiments,  vasoconstriction being  replaced by vasodilata-
tion.  Hypertension  which  had  resulted  from  partial  constriction  of  the
renal artery and the injection of adrenalin  (11)  was abolished.
Reactions.-Various reactions  followed the intravenous  administration  of tyrosinase.
Anesthetized  rats, whether  normal or hypertensive,  consistently  exhibited bradycardia
5 to 15 minutes after the injection, the lowered cardiac rate remaining while the rats were
observed  (up  to  2 hours)  and  sometimes  persisting  for 24  hours.  A few  animals  ex-
hibited diarrhea for a day or two after injection.  Anesthetized dogs with hypertension
developed bradycardia a few minutes after injection.  Unanesthetized  dogs, normal and
hypertensive,  exhibited  vomiting,  diarrhea,  tenesmus, and slowing of the pulse, 5 to 30
minutes  after  injection,  lasting  one to  two  hours.  The  intestines of one  animal were
seen  to be  markedly  contracted.  It was  also noticed  that  excited  dogs quieted  while
the  injection  was being given.  Reactions  of  this  nature  were  greater  in  hypertensive
dogs,  sometimes altering their general behavior; normal ones  were less affected.  These
events  did not occur if atropine had been  injected.  Tyrosinase, in rats and dogs, acted
therefore like a cholinergic drug.  Little or no change was seen in the behavior of normal
rabbits, guinea  pigs, or monkeys  after intravenous  injection, but the blood pressure  was
not estimated.
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The  Antigenicity  of  Tyrosinase
The  preparation  of  tyrosinase  used  is  a  good  antigen  in  rabbits.  A
strong antiserum was prepared and precipitins were detectable at an antigen
dilution  of  1:400,000.  When  a  solution  of  tyrosinase  was  precipitated
by this serum, most (9/10ths)  of the activity of the enzyme was removed.
The precipitate  was, however,  readily soluble  in water  and  upon solution
the  enzyme  became  completely  active.
Six guinea  pigs  were  sensitized to  tyrosinase by repeated intraperitoneal
injections.  Subsequent  intravenous  injections  failed  to  produce  signs  of
anaphylaxis.  Sensitized rabbits  likewise  showed  no  signs  of  anaphylaxis
after  intravenous  injection.
The  Effect  of  Other Enzymes  on  Hypertension
Two enzymes having the property of attacking the guanidine linkage  in
such  compounds  as arginine,  guanidine,  and  creatinine  were  injected  into
14 rats  and four  dogs.  Arginase obtained  from  Dr.  Ren6  J. Dubos  and
prepared  by him  from  soil bacteria  was  found  to  raise  blood  pressure  in
hypertensive animals while that of normal ones was less affected.  Arginase
prepared  from livers  was found to have a similar action,  although  less pro-
nounced.  Both preparations  were  far  from pure,  and  no conclusions  can
be  drawn  from  these  results.
DISCUSSION
From  these  experiments  there  is  little doubt  that the  injection  of this
preparation  of tyrosinase  in  suitable  doses  into  rats  and  dogs  exhibiting
experimental  hypertension  of the renal variety  results  in  reduction  of the
blood pressure.  Furthermore, there is a difference in the response of normal
animals, their blood pressure being less or not at all affected.  Although the
possibility exists that the hypotensive action of this enzyme  is a non-specific
one, the most probable  explanation of this phenomenon  is that some  sub-
stance present in the hypertensive state is altered.  Because tyrosinase acts
only on compounds  containing  a mono-  or ortho-di-hydroxybenzene  struc-
ture in the molecule, the substance which is changed must contain a phenolic
group  of this nature.
Two possibilities come to mind:  the pressor substance itself is inactivated
by or through the medium of  the enzyme,  or some  other compound,  prob-
ably  phenolic,  is  altered  to  form  a  depressor  substance.  From  what  is
known  of  pressor substances  in arterial hypertension  the first explanation
is more  likely; there  is  no evidence  for the  second.
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There  are  at  least  three  possible  ways  in  which  tyrosinase  may  act.
First,  all  compounds  containing  catechol  or  phenolic  configurations  are
probably  oxidized  by  the  enzyme  to  quinones.  This  change  from  the
benzenoid  to  the  quinoid  configuration  is  accompanied  by an  alteration
in the physiological  action of the compound concerned,  as is well  illustrated
in the case of adrenalin and tyramine.  In this way tyrosinase may destroy
some  as yet  unknown  phenolic  pressor  substance  which is  responsible  for
hypertension.
A  second  possibility  is that  the orthoquinones  produced  by the action
of tyrosinase on phenolic substances have  special properties.  These ortho-
quinones,  being  powerful  oxidizing  agents,  may  themselves  destroy  some
pressor  substance  of  lower  oxidation-reduction  potential  in  a  manner
analogous  to the destruction of ascorbic acid by orthoquinones  (12).  These
substances  themselves  can  oxidize  amines.
The  third  explanation  is  that  adrenalin  is  destroyed.  Arterial  hyper-
tension can be produced in brief experiments  by very small amounts of this
hormone if one kidney is ischemic.  Adrenalin in these amounts is a power-
ful renal vasoconstrictor  in dogs  (11).  Destruction of adrenalin may allow
renal  vasodilatation.  In  that event  the blood  pressure  would  fall.
By whatever method tyrosinase acts, it appears to have an action specific
for  arterial  hypertension  of  the  variety  produced  in  these  experiments.
Furthermore,  it  inactivates  various  pressor  substances.  The  part  that
these materials play in the existence  of hypertension  is not known, but each
behaves  as  a  pressor  substance  conceivably  responsible  for  bringing  on
elevation of the blood pressure.
It was  shown  that  renin was  inactivated  by tyrosinase  under  certain
conditions, that is, when catechol or when some product of the deterioration
of renin was present.  Tyrosinase acts upon catechol to form orthoquinone,
which  is  an  oxidizing  agent.  It is likely,  therefore,  that the inactivation
of  renin  depends  upon the non-specific  action  of  another  substance.  The
significance  of an  event  such as this  in the bodies  of  animals  is unknown.
If  renin  were  concerned  in  hypertension  it  might  be  inactivated  in  this
manner.
Under  certain  conditions  angiotonin is  also  inactivated  by tyrosinase,
that  is,  when  serum  is present.  This reaction  does  not depend  upon the
presence  of  catechol.  Although  the  preparation  of  angiotonin  used  was
acted  upon  directly  by the enzyme,  the reaction  was  complete  only after
the  addition  of  serum.  Angiotonin  according  to  Page  (3)  must  be  acti-
vated by some substance present in serum.  These results suggest that the
product  of  the activation  of  angiotonin is a phenolic substance.
548HENRY  A.  SCHROEDER  AND  MARK  H.  ADAMS
Victor's substance, likewise,  in the preparations obtained, was inactivated
directly by tyrosinase,  suggesting that this material also contains a phenolic
configuration.  The inactivation of adrenalin and tyramine is accomplished
by direct action of the enzyme.
Light  is thrown  on at  least one  part of the action  of  tyrosinase  by the
nature  of the various reactions  which follow intravenous injection.  These
effects  suggest  that  tyrosinase  acts  as  a  cholinergic  drug.  This enzyme,
however,  alters  sympathicomimetic  substances.  The  more  likely  ex-
planation,  therefore,  is that  the sympathetic  nervous  system is depressed.
There is no explanation for the lowering of the urea nitrogen  in the blood
of dogs.  This  change was  seen  consistently,  and  did  not depend  upon  a
change in amino acids.  The least that can be said is that renal insufficiency
did not accompany  the lowered  blood pressure.
The antigenic action of tyrosinase presents a difficultproblem.  Although
it does not occasion anaphylactic  shock in guinea pigs, and dogs developed
no  signs  of sensitivity even  after  5  months  of intermittent  use,  antibodies
(precipitins)  have  been  demonstrated in  human beings  after subcutaneous
injection.  Further studies  on this subject, both in  animals  and in human
beings,  are  in  progress.
From  these  studies  it  becomes  obvious  that  the  use  of  tyrosinase,  an
enzyme specific in altering phenolic compounds, effectively  combats arterial
hypertension  induced  by various  methods  in  rats  and  in  dogs.  The  use
of  this  enzyme  in  human  beings  is  now  being  investigated.
CONCLUSIONS
1. The intravenous injection  of  tyrosinase,  a phenolic  oxidase  obtained
from mushrooms,  consistently lowers the blood pressure of rats made hyper-
tensive  by three  different  methods, while  on the average  not affecting  the
blood pressure  of normal animals.
2.  The  intravenous  and  intramuscular  injection  of  tyrosinase  lowers
blood  pressure  in  dogs  made  hypertensive  by  the  method  of  Goldblatt,
while affecting that of normal ones to a less extent.
3.  Tyrosinase  inactivates  renin,  angiotonin,  Victor's pressor  substance,
adrenalin, and tyramine in vitro, and alters the response of the blood pressure
to  these  substances  in rats  and  dogs.
4.  Renal function  of hypertensive  dogs is not depressed  when  the blood
pressure  is  lowered  by tyrosinase.
5.  Tyrosinase  is  an  effective  substance  for  combating  experimental
arterial hypertension.  It is probable that some phenolic  substance present
in  hypertension  is  altered.
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After this paper  was  submitted  for publication,  a second  sample of angiotonin  was
received  from Dr. Page,  and  the effect  of  tyrosinase upon  it  ascertained.  Serum was
not  necessary  in  this  instance  for  complete  inactivation  of  its  pressor  action  by
small  amounts  of  tyrosinase.  Amounts  of  the  enzyme  as  small  as  0.2  units  abol-
ished the  pressor  effect  of  one  "rat  dose"  of  this solution  of  angiotonin,  and  caused
approximately  equal absorption  of  oxygen  in the  presence  and absence  of serum.
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EXPLANATION  OF  PLATES
PLATE  29
FIG. 1. The effect  of the intravenous injection of tyrosinase in rats.  The curves are
records of blood pressure as photographed with Hamilton's manometer; the upper figures
show the systolic,  the lower the diastolic pressure.  Arrows indicate points of injection.
The time is in minutes.  Rats 42,  43, and 45 are normal; rat G 140 was  made  hyperten-
sive  by the Goldblatt technique,  and rat H 100  by the production  of hydronephrosis.
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PLATE  29PLATE  30
FIG.  2.  The  inactivation  of  angiotonin  by  tyrosinase.  A,  rat H  148, hypertensive.
The first  curve  shows  the effect  on  blood pressure  of one  rat dose  of angiotonin.  The
pulse  pressure has  increased.  One  rat dose  of  angiotonin  and 500  units of tyrosinase,
shaken  at room temperature  for  20 minutes  were then  administered.  There was  a de-
crease  in  the  activity  of  the former.  The  third curve  shows  the effect  of the mixture
when catechol was added.  Angiotonin  was still active.  In the fourth  curve, a mixture
of angiotonin, tyrosinase, and serum was injected.  Very little activity on blood pressure
resulted.  The last curve again shows the  effect of angiotonin alone.  The rat was  made
hypertensive  by the production  of unilateral hydronephrosis;  notice  the fall in the level
of blood pressure after the first injection of tyrosinase.  B, rat 67, normal.  The inactiva-
tion  of  angiotonin  by  small  amounts  of  tyrosinase.  The  first  curve  shows  the  effect
on blood pressure  of one rat dose of angiotonin and 6 mg. gelatin which had been shaken
in  the Warburg  apparatus.  The second demonstrates  the effect  of the same amount  of
angiotonin,  0.1  cc.  serum, and 2.5  units of tyrosinase  similarly treated.  Angiotonin  was
inactive.  In the third curve  is  seen the effect  when  gelatin  was substituted  for  serum.
The  last curve  shows the  effect  of tyrosinase and  gelatin,  an inert  mixture.THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  73
(Schroeder  and  Adams:  Effect  of tyrosinase  on  hypertension)
PLATE  30